Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on June 12, 2007
JNCI Journal of the National Cancer Institute 2007 99(12):976-977; doi:10.1093/jnci/djm009
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/12/976    most recent
djm009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Rini, B. I.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rini, B. I.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Brian I. Rini

Correspondence to: Brian I. Rini, MD, Department of Solid Tumor Oncology and Urology, Cleveland Clinic Taussig Cancer Center, 9500 Euclid Ave, Desk R35, Cleveland, OH 44195 (e-mail: rinib2@ccf.org).

The first 10% of the full text of this article appears below.

We appreciate the interest of Feldman et al. and of Garfield et al. in our recent publication regarding thyroid function test (TFT) abnormalities in metastatic renal cell carcinoma (RCC) patients receiving sunitinib (1). The important conclusion is that hypothyroidism is commonly observed with sunitinib therapy and necessitates . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Darren R. Feldman, Andrew J. Martorella, Richard J. Robbins, and Robert J. Motzer
J Natl Cancer Inst 2007 99: 974-975. [Extract] [Full Text] [PDF]

Re: Hypothyroidism in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
David H. Garfield, Aleck Hercbergs, and Paul J. Davis
J Natl Cancer Inst 2007 99: 975-976. [Extract] [Full Text] [PDF]